MENU
+Compare
SAFLY
Stock ticker: OTC
AS OF
Nov 7 closing price
Price
$4.00
Change
+$0.61 (+17.99%)
Capitalization
852.13M

SAFLY stock forecast, quote, news & analysis

Safilo Group SpA makes sunglasses and prescription eyewear... Show more

SAFLY
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for SAFLY with price predictions
Nov 12, 2025

SAFLY's Stochastic Oscillator is staying in overbought zone for 1 day

Expect a price pull-back in the near future.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis
Bullish Trend Analysis

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SAFLY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.693) is normal, around the industry mean (10.242). P/E Ratio (15.452) is within average values for comparable stocks, (158.743). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.733). SAFLY has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (0.718) is also within normal values, averaging (111.072).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I.Advisor
published Dividends

SAFLY paid dividends on November 08, 2021

Safilo Group Spa SAFLY Stock Dividends
А quarterly dividend of $0.28 per share was paid with a record date of November 08, 2021, and an ex-dividend date of October 29, 2021. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Intuitive Surgical (NASDAQ:ISRG), Align Technology (NASDAQ:ALGN).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 12.02B. The market cap for tickers in the group ranges from 246 to 202.93B. ISRG holds the highest valuation in this group at 202.93B. The lowest valued company is PEMTF at 246.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was 2%. For the same Industry, the average monthly price growth was 0%, and the average quarterly price growth was 6%. TUTH experienced the highest price growth at 192%, while SMTI experienced the biggest fall at -24%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was -3%. For the same stocks of the Industry, the average monthly volume growth was 48% and the average quarterly volume growth was 37%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 62
Price Growth Rating: 60
SMR Rating: 80
Profit Risk Rating: 92
Seasonality Score: 26 (-100 ... +100)
View a ticker or compare two or three
SAFLY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
Settima Strada, 15
Phone
+39 496985111
Employees
4442
Web
https://www.safilogroup.com